Company / Current Assets
CUMBERLAND PHARMACEUTICALS INC Current Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$37.1M
FY2025
5-year range
$35.7M / $45.9M
FY2021-FY2025
Trend
+1.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Assets has fluctuated over the past 10 years, ranging from $36M in FY2023 to $69M in FY2017.
Based on SEC 10-K filings.
$37M in FY2025 with a 5-year CAGR of -5.8%.
Improved from $36M to $37M over the past 2 years.
Current Assets over time
Growth rates
- 3-Year CAGR
- -6.9%
- 5-Year CAGR
- -5.8%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -5.8%, indicating a declining trend.
- In FY2025, current assets increased 1.7% year-over-year.
- Peak current assets was recorded in FY2017.
- Lowest current assets in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score 0.11 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $37.1M | +1.7% |
| FY2024 | $36.5M | +2.1% |
| FY2023 | $35.7M | -22.1% |
| FY2022 | $45.9M | +0.4% |
| FY2021 | $45.7M | -8.6% |
| FY2020 | $50.0M | -0.4% |
| FY2019 | $50.2M | -15.1% |
| FY2018 | $59.1M | -13.9% |
| FY2017 | $68.7M | +4.8% |
| FY2016 | $65.5M | -2.3% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026